DNA and Gene Cloning Services Market: Distribution by Type of Service Offered (Gene Synthesis, Custom Cloning, Sub-cloning and Others), Type of Gene (Standard Gene, Complex Gene and Others), Company Size (Small, Mid-sized and Large), End-User Industry (Academic and R&D, Pharmaceutical and Biotechnology Companies, and Others) and Key Geographies (North America, Europe, Asia-Pacific, Latin America and MENA): Industry Trends and Global Forecasts, 2022-2035

  • Lowest Price Guaranteed From USD 5,899

  • Published
    August 2022

  • Pages
    202

  • View Count
    746

Example Insights

DNA-and-Gene-Cloning-Services-Market-Context-thumb

DNA-and-Gene-Cloning-Services-Market-List-of-Gene-Cloning-Service-Providers-thumb DNA-and-Gene-Cloning-Services-Market-Distribution-by-Type-of-Service-thumb
DNA-and-Gene-Cloning-Services-Market-Benchmark-Analysis-thumb DNA-and-Gene-Cloning-Services-Market-Publication-Analysis-thumb DNA-and-Gene-Cloning-Services-Market-Patent-Analysis-thumb
DNA-and-Gene-Cloning-Services-Market-Cumulative-Year-wise-Trend-thumb DNA-and-Gene-Cloning-Services-Market-Likely-Growth-Scenarios-thumb DNA-and-Gene-Cloning-Services-Market-Distribution-by-Company-Size-thumb

Overview

In 1973, a group of scientists reported that individual genes can be cloned and isolated by cleaving DNA enzymatically into DNA fragments. Over time, gene and DNA cloning has proved to be an important tool for researchers in their studies focused on genetics. The evolution of genetic engineering and cloning techniques has allowed for alterations in the genome of microorganisms, thereby enabling the production of substances having various research and therapeutic applications. Further, cloning can be used to produce gene therapies for the treatment of serious disease indications, such as cystic fibrosis, cancer, AIDS and others. It is interesting to note that gene cloning can be a potential solution to organ scarcity. It also plays an important role in synthesis of antibiotics, vitamins and hormones. Given the various applications of DNA and gene cloning, scientists have taken initiatives for constructing gene libraries having a collection of cloned DNA. However, the process of successful DNA cloning and gene cloning is associated with several challenges and complications, such as gene toxicity, requirement of a specific insert size or large vector, unstable DNA elements, and the presence of DNA secondary structures. In order to overcome these challenges and obtain a high-quality and stable finished product, the outsourcing of DNA and gene cloning is considered as a preferable option, among other alternatives, by companies engaged in DNA and gene cloning.  

Currently, several players offer services for DNA cloning and gene cloning. The DNA cloning and gene cloning services market is highly fragmented, featuring presence of various start-ups, mid-sized firms and well-established players. These players offer a wide range of services for DNA and gene cloning with different types of cloning methods. Further, it is worth mentioning that extensive research is being conducted for DNA cloning technologies; this is evident from more than 6,900 research articles that have been published for DNA cloning technologies in the past few years. In addition, more than 35 global events have been organized to discuss about the recent trends related to DNA and gene cloning. Driven by the growing demand for gene therapies, and the introduction and adoption of novel and advanced DNA cloning technologies, the DNA cloning and gene cloning services market is anticipated to witness steady growth in the coming years.

Scope of the Report

The ‘DNA and Gene Cloning Services Market – Distribution by Type of Service Offered (Gene Synthesis, Custom Cloning, Sub-cloning and Others), Type of Gene (Standard Gene, Complex Gene and Others), Company Size (Small, Mid-sized and Large), End-User Industry (Academic and R&D, Pharmaceutical and Biotechnology Companies, and Others) and Key Geographies (North America, Europe, Asia-Pacific, Latin America and MENA): Industry Trends and Global Forecasts, 2022-2035’ report features an extensive study of the current market landscape and future potential of the DNA and gene cloning services market. The study features an in-depth analysis, highlighting the capabilities of DNA cloning and gene cloning service providers. Amongst other elements, the report features:

  • A detailed overview of the overall market landscape of DNA cloning and gene cloning service providers, based on several relevant parameters, such as information on their year of establishment, company size (in terms of employee count), region of headquarters (North America, Europe, Asia-Pacific and rest of the world). In addition to this, the chapter also features information on type of service(s) offered (gene synthesis, custom cloning, sub-cloning and others), cloning method(s) used (Restriction Enzyme Based Cloning, PCR Cloning, Ligation Independent Cloning, TA Cloning, Blunt End Cloning, Seamless Cloning and Recombinational Cloning), type of gene(s) cloned (standard gene and complex gene), expression system(s) used (bacterial, mammalian, insect and yeast), cloning vector(s) used (plasmids, bacteriophages, bacterial artificial chromosomes, yeast artificial chromosomes and mammalian artificial chromosomes) and end-user industry (academic and R&D, pharmaceutical and biotechnology companies, and others). 
  • An insightful benchmark analysis of the DNA and gene cloning service providers, located in North America, Europe, and Asia-Pacific and Rest of the World. The analysis compares the service providers on the basis of various parameters, such as number of cloning method(s) used, number of expression system(s) used, number of cloning vector(s) used and number of end-user(s). It also highlights the top players in various geographies.   
  • Elaborate profiles of the key players involved in providing services for DNA and gene cloning. Each profile features a brief overview of the company, its financial information (if available), details on its service portfolio and recent developments with an informed future outlook.
  • An in-depth analysis of patents related to DNA and gene cloning, filed / granted since 2017, based on several relevant parameters, such as patent type, publication year, application year, geographical location, Cooperative Patent Classification (CPC) symbols, emerging focus area, type of applicant, leading players (on the basis of number of patents), leading assignees (on the basis of number of patents) and patent benchmarking. In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents.
  • An analysis of more than 6,900 peer-reviewed, scientific articles related to research on DNA and gene cloning, which have been published between 2017 and 2022, including analysis based on parameters, such as year of publication, type of cloning, key focus area, popular journals (in terms of number of articles published in this domain), leading authors (in terms of number of articles published in this domain) and leading first authors (in terms of number of articles published in this domain).
  • An in-depth analysis of recent events (conferences / seminars / summits / trainings / webinars / workshops) related to DNA and gene cloning that were organized / planned. It features an analysis based on the year of occurrence of event, event platform, type of event, geographical distribution, emerging agendas / key focus areas, most active event speakers (in terms of number of events), seniority level of event speakers and geographical mapping of the upcoming events.
  • A case study on the DNA cloning kits developers, providing information and detailed analysis on kit components, number of reactions, type of cloning method used, type of fragment(s) cloned, cloning time, efficacy and kit shelf life. Further, it also includes a study on the DNA cloning reagents developers, along with a detailed analysis based on reagents’ unit size, concentration, components of reagents, exonuclease activity, product overhangs, heat inactivation temperature and storage temperature. In addition to this, the chapter concludes with the overview of geographical distribution of DNA cloning kits and reagents developers, along with DNA and gene cloning service providers.

One of the key objectives of the report was to evaluate the current opportunity and future potential associated with the DNA and gene cloning services market, over the coming 13 years. We have provided informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as [A] type of service offered (gene synthesis, custom cloning, sub-cloning and others), [B] type of gene (standard gene, complex gene and others), [C] company size (small, mid-sized and large), [D] end-user industry (academic and R&D, pharmaceutical and biotechnology companies and others), [E] key geographical regions (North America, Europe, Asia-Pacific, Latin America and MENA). To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry.

Key Questions Answered

  • Who are the leading players offering DNA and gene cloning services?
  • Which global regions are considered as the hub of DNA cloning kit and reagent developers?
  • What is the relative competitiveness of different DNA and gene cloning service providers?
  • How has the intellectual property landscape in this field evolved over the years?
  • What is the focus of various publications related to DNA and gene cloning? 
  • What is the key agenda of various global events / conferences related to DNA and gene cloning?
  • How is the current and future market opportunity, likely to be distributed across key market segments?

Contents

Chapter Outlines

Chapter 2 is an executive summary of the key insights captured during our research. It offers a high-level view on the likely evolution of the DNA and gene cloning services market in the short to mid-term, and long term.

Chapter 3 provides a general overview of DNA cloning with information on the methods of DNA cloning (Restriction Enzyme Based Cloning, PCR Cloning, Ligation Independent Cloning, TA Cloning, Blunt End Cloning, Seamless Cloning and Recombinational Cloning). Further, it includes details on the techniques used in DNA and gene cloning, types of genes cloned, different types of expression systems and cloning vectors used in DNA and gene cloning. The chapter concludes with a discussion on the applications, challenges associated and need for outsourcing DNA and gene cloning and factors that are likely to contribute to growth in this domain.

Chapter 4 provides an overview of the current market landscape of DNA and gene cloning service providers, based on several relevant parameters, such as information on their year of establishment, company size, region of headquarters, location of headquarters, company size and region of headquarters. In addition, the chapter features information on DNA and gene cloning services and a detailed analysis based on several relevant parameters, such as information on the type of service(s) offered (gene synthesis, custom cloning, sub-cloning and others), type of cloning method(s) employed (Restriction Enzyme Based Cloning, PCR Cloning, Ligation Independent Cloning, TA Cloning, Blunt End Cloning, Seamless Cloning and Recombinational Cloning), type of gene(s) cloned (standard gene and complex gene), type of expression system(s) used (bacterial, mammalian, insect and yeast), type of cloning vector(s) used (plasmids, bacteriophages, bacterial artificial chromosomes, yeast artificial chromosomes and mammalian artificial chromosomes) and end user industry (academic and R&D, pharmaceutical and biotechnology companies, and others).  

Chapter 5 presents an insightful benchmark analysis of the DNA and gene cloning service providers, located in North America, Europe, and Asia-Pacific and Rest of the World. The analysis compares the service providers on the basis of various parameters, such as number of cloning method(s) employed, number of expression system(s) used, number of cloning vector(s) used and number of end-user(s). In the chapter, the top stakeholders in each geography have been plotted on a spider web for their respective capabilities.

Chapter 6 features elaborate profiles of the key players involved in providing services for DNA and gene cloning. Each profile features a brief overview of the company, its financial information (if available), details on its service portfolio and recent developments with an informed future outlook.

Chapter 7 consists of an analysis of patents related to DNA and gene cloning, filed / granted since 2017, based on several relevant parameters, such as patent type, publication year, application year, geographical location, Cooperative Patent Classification (CPC) symbols, emerging focus area, type of applicant, leading players (on the basis of number of patents), leading assignees (on the basis of number of patents) and patent benchmarking. In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents.

Chapter 8 provides a detailed review of more than 6,900 peer-reviewed, scientific articles related to research on DNA and gene cloning, which have been published between 2017 and 2022, including analysis based on parameters, such as year of publication, type of cloning, key focus area, popular journals (in terms of number of articles published in this domain), leading authors (in terms of number of articles published in this domain) and leading first authors (in terms of number of articles published in this domain).

Chapter 9 provides an analysis of recent events (conferences / seminars / summits / trainings / webinars / workshops) related to DNA and gene cloning that were organized / planned to be organized. It features an analysis based on the year of occurrence of event, event platform, type of event, geographical distribution, emerging agendas / key focus areas, most active event speakers (in terms of number of events), seniority level of event speakers and geographical mapping of the upcoming events.

Chapter 10 presents an insightful market forecast analysis, highlighting the likely growth of the DNA and gene cloning services market till the year 2035. In order to provide details on the future opportunity, our projections have been segmented on the basis of [A] type of service offered (gene synthesis, custom cloning, sub-cloning and others), [B] type of gene (standard gene, complex gene and others), [C] company size (small, mid-sized and large), [D] end user industry (academic and R&D, pharmaceutical and biotechnology companies, and others), [E] key geographical regions (North America, Europe, Asia-Pacific, Latin America and MENA).

Chapter 11 presents a case study of the DNA cloning kits developers. The chapter features information and detailed analysis on kit components, number of reactions, type of cloning method used, type of fragment(s) cloned, cloning time, efficacy and kit shelf life. Further, it also includes the study of the DNA cloning reagents developers, with detailed analysis on reagents’ unit size, concentration, components of reagents, exonuclease activity, product overhangs, heat inactivation temperature and storage temperature. In addition to this, the chapter concludes with the overview of geographical distribution of DNA cloning kits and reagents developers, along with DNA and gene cloning service providers.

Chapter 12 summarizes the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 13 provides the transcripts of the interviews conducted with representatives from renowned organizations that are engaged in providing services of DNA and gene cloning. 

Chapter 14 is an appendix, that provides tabulated data and numbers for all the figures included in the report.

Chapter 15 is an appendix that provides the list of companies and organizations that have been mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to DNA Cloning
3.3. Methods of DNA Cloning
3.3.1. Restriction Enzyme Based Cloning
3.3.2. PCR Cloning
3.3.3. Ligation Independent Cloning
3.3.4. TA Cloning
3.3.5. Blunt End Cloning
3.3.6. Seamless Cloning
3.3.7. Recombinational Cloning

3.4. Techniques Used in DNA and Gene Cloning
3.4.1. Molecular Cloning
3.4.2. Genetic Synthesis
3.4.3. Custom Cloning

3.5. Types of Genes Cloned
3.5.2. Standard Genes
3.5.3. Complex Genes

3.6. Type of Expression Systems Used in DNA and Gene Cloning
3.6.1. Mammalian Expression System
3.6.2. Insect Expression System
3.6.3. Bacterial Expression System
3.6.4. Plant Expression System
3.6.5. Yeast Expression System

3.7. Cloning Vectors
3.7.1. Plasmids
3.7.2. Bacteriophages
3.7.3. Bacterial Artificial Chromosomes (BACs)
3.7.4. Yeast Artificial Chromosomes (YACs)
3.7.5. Mammalian Artificial Chromosomes (MACs)

3.8. Applications of DNA and Gene Cloning
3.9. Challenges associated with DNA and Gene Cloning
3.10. Outsourcing of DNA and Gene Cloning Services
3.11. Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. DNA and Gene Cloning Service Providers Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Region of Headquarters
4.2.4. Analysis by Company Size and Region of Headquarters

4.3. DNA and Gene Cloning Services: Overall Market Landscape
4.3.1. Analysis by Type of Service(s) Offered
4.3.2. Analysis by Cloning Method(s) Used
4.3.3. Analysis by Type of Gene(s) Cloned
4.3.4. Analysis by Expression System(s) Used
4.3.5. Analysis by Cloning Vector(s) Used
4.3.6. Analysis by End User

5. BENCHMARK ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Benchmark Analysis: Peer Groups
5.4.1. Benchmark Analysis: North America (Peer Group I)
5.4.2. Benchmark Analysis: North America (Peer Group II)
5.4.3. Benchmark Analysis: North America (Peer Group III)
5.4.4. Benchmark Analysis: Europe (Peer Group IV)
5.4.5. Benchmark Analysis: Europe (Peer Group V)
5.4.6. Benchmark Analysis: Asia-Pacific and Rest of the World (Peer Group VI)
5.4.7. Benchmark Analysis: Asia-Pacific and Rest of the World (Peer Group VII)

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Aragen Life Sciences
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Bio-Techne
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Service Portfolio
6.3.4. Recent Developments and Future Outlook

6.4. Charles River Laboratories
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Service Portfolio
6.4.4. Recent Developments and Future Outlook

6.5. Curia
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. Eurofins
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Service Portfolio
6.6.4. Recent Developments and Future Outlook

6.7. GenScript
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Service Portfolio
6.7.4. Recent Developments and Future Outlook

6.8. Integrated DNA Technologies
6.8.1. Company Overview
6.8.2. Service Portfolio
6.8.3. Recent Developments and Future outlook

6.9. MedGenome
6.9.1. Company Overview
6.9.2. Service Portfolio
6.9.3. Recent Developments and Future Outlook

6.10. Sino Biological
6.10.1. Company Overview
6.10.2. Service Portfolio
6.10.3. Recent Developments and Future Outlook

6.11. Syngene
6.11.1. Company Overview
6.11.2. Financial Information
6.11.3. Service Portfolio
6.11.4. Recent Developments and Future Outlook

6.12. Twist Bioscience
6.12.1. Company Overview
6.12.2. Financial Information
6.12.3. Service Portfolio
6.12.4. Recent Developments and Future Outlook

7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. DNA and Gene Cloning: Patent Analysis
7.3.1. Analysis by Publication Year
7.3.2. Analysis by Application Year
7.3.3. Analysis by Annual Number of Granted Patents and Patent Applications
7.3.4. Analysis by Geographical Location
7.3.5. Analysis by CPC Symbols
7.3.6. Analysis by Focus Area
7.3.7. Analysis by Type of Applicant
7.3.8. Leading Players: Analysis by Number of Patents
7.3.9. Leading Individual Assignees: Analysis by Number of Patents

7.4. DNA and Gene Cloning: Patent Benchmarking Analysis
7.4.1. Analysis by Patent Characteristics
7.5. DNA and Gene Cloning: Patent Valuation Analysis
7.6. Leading Patents by Number of Citations

8. PUBLICATION ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.2.1. Analysis by Year of Publication
8.2.2. Analysis by Type of Cloning
8.2.3. Word Cloud: Emerging Focus Areas
8.2.4. Popular Journals: Analysis by Number of Publications
8.2.5. Leading Authors: Analysis by Number of Publications
8.2.6. Leading First Authors: Analysis by Number of Publications

9. GLOBAL EVENT ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. List of Global Events related to DNA and Gene Cloning
9.3.1. Analysis by Year of Event
9.3.2. Analysis by Event Platform
9.3.3. Analysis by Type of Event
9.3.4. Analysis by Geography
9.3.5. Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Area
9.3.6. Most Active Participants: Analysis by Number of Events
9.3.7. Analysis by Seniority Level of Event Speakers
9.3.8. Geographical Mapping of Upcoming Events

10. MARKET FORECAST
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions

10.3. Global DNA and Gene Cloning Services Market, 2022-2035
10.3.1. DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Services Offered
10.3.1.1. DNA and Gene Cloning Services Market for Gene Synthesis, 2022-2035
10.3.1.2. DNA and Gene Cloning Services Market for Custom Cloning, 2022-2035
10.3.1.3. DNA and Gene Cloning Services Market for Sub-cloning, 2022-2035
10.3.1.4. DNA and Gene Cloning Services Market for Other Services, 2022-2035

10.3.2. DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Type of Genes Cloned
10.3.2.1. DNA and Gene Cloning Services Market for Standard Gene, 2022-2035
10.3.2.2. DNA and Gene Cloning Services Market for Complex Gene, 2022-2035
10.3.2.3. DNA and Gene Cloning Services Market for Other Genes, 2022-2035

10.3.3. DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Company Size
10.3.3.1. DNA and Gene Cloning Services Market for Small Companies, 2022-2035
10.3.3.2. DNA and Gene Cloning Services Market for Mid-sized Companies, 2022-2035
10.3.3.3. DNA and Gene Cloning Services Market for Large Companies, 2022-2035

10.3.4. DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by End User Industry
10.3.4.1. DNA and Gene Cloning Services Market for Academic and R&D, 2022-2035
10.3.4.2. DNA and Gene Cloning Services Market for Pharmaceutical and Biotechnology Companies, 2022-2035
10.3.4.3. DNA and Gene Cloning Services Market for Other End Users, 2022-2035

10.3.5. DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Key Geographical Regions
10.3.5.1. DNA and Gene Cloning Services Market in North America, 2022-2035
10.3.5.2. DNA and Gene Cloning Services Market in Europe, 2022-2035
10.3.5.3. DNA and Gene Cloning Services Market in Asia-Pacific, 2022-2035
10.3.5.4. DNA and Gene Cloning Services Market in Latin America, 2022-2035
10.3.5.5. DNA and Gene Cloning Services Market in MENA, 2022-2035

11. CASE STUDY: DNA AND GENE CLONING KITS AND REAGENTS
11.1. Chapter Overview
11.2. DNA Cloning Kits
11.2.1. Analysis by Kit Components
11.2.2. Analysis by Number of Reactions
11.2.3. Analysis by Type of Cloning Method Used
11.2.4. Analysis by Type of Fragment(s) Cloned
11.2.5. Analysis by Cloning Time
11.2.6. Analysis by Efficacy
11.2.7. Analysis by Kit Shelf Life

11.3. DNA Cloning Reagents
11.3.1. Analysis by Unit Size
11.3.2. Analysis by Reagent Concentration
11.3.3. Analysis by Reagent Components
11.3.4. Analysis by Exonuclease Activity
11.3.5. Analysis by Product Overhangs
11.3.6. Analysis by Heat Inactivation Temperature
11.3.7. Analysis by Storage Temperature

11.4. Players in North America
11.4.1. DNA Cloning Kit Developers
11.4.2. DNA Cloning Reagent Developers
11.4.3. DNA Cloning Service Providers

11.5. Players in Europe
11.5.1. DNA Cloning Kit Developers
11.5.2. DNA Cloning Reagent Developers
11.5.3. DNA Cloning Service Providers

11.6. Players in Asia-Pacific and Rest of the World
11.6.1. DNA Cloning Kit Developers
11.6.2. DNA Cloning Reagent Developers
11.6.3. DNA Cloning Service Providers

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

14. APPENDIX I: TABULATED DATA

15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: DNA and Gene Cloning Services Market Landscape
Figure 2.2 Executive Summary: Patent Analysis
Figure 2.3 Executive Summary: Publication Analysis
Figure 2.4 Executive Summary: Global Event Analysis
Figure 2.5 Executive Summary: Market Forecast
Figure 3.1 Mechanism of Restriction Enzyme Based Cloning
Figure 3.2 Mechanism of PCR Cloning
Figure 3.3 Mechanism of Ligation-independent cloning
Figure 3.4 Mechanism of TA cloning
Figure 3.5 Mechanism of Blunt End Cloning
Figure 3.5 Mechanism of Seamless Cloning
Figure 3.6 Mechanism of Recombinational Cloning
Figure 3.7 Mechanism of Molecular Cloning
Figure 3.8 Types of Expression Systems
Figure 3.9 Applications of DNA and Gene Cloning
Figure 4.1 DNA and Gene Cloning Service Providers: Distribution by Year of Establishment
Figure 4.2 DNA and Gene Cloning Service Providers: Distribution by Company Size
Figure 4.3 DNA and Gene Cloning Service Providers: Distribution by Region of Headquarters
Figure 4.4 DNA and Gene Cloning Service Providers: Distribution by Location of Headquarters
Figure 4.5 DNA and Gene Cloning Service Providers: Distribution by Company Size and Region of Headquarters
Figure 4.6 DNA and Gene Cloning Services: Distribution by Type of Service(s) Offered
Figure 4.7 DNA and Gene Cloning Services: Distribution by Type of Cloning Method(s) Used
Figure 4.8 DNA and Gene Cloning Services: Distribution by Type of Gene(s) Cloned
Figure 4.9 DNA and Gene Cloning Services: Distribution by Type of Expression System(s) Used
Figure 4.10 DNA and Gene Cloning Services: Distribution by Type of Cloning Vector(s) Used
Figure 4.11 DNA and Gene Cloning Services: Distribution by End User Industry
Figure 5.1 Benchmark Analysis: Distribution by Company Size
Figure 5.2 Company Competitiveness: Players based in North America (Peer Group I)
Figure 5.3 Benchmark Analysis: Players based in North America (Peer Group I)
Figure 5.4 Company Competitiveness: Players based in North America (Peer Group II)
Figure 5.5 Benchmark Analysis: Players based in North America (Peer Group II)
Figure 5.6 Company Competitiveness: Players based in North America (Peer Group III)
Figure 5.7 Benchmark Analysis: Players based in North America (Peer Group III)
Figure 5.8 Company Competitiveness: Players based in Europe (Peer Group IV)
Figure 5.9 Benchmark Analysis: Players based in Europe (Peer Group IV)
Figure 5.10 Company Competitiveness: Players based in Europe (Peer Group V)
Figure 5.11 Benchmark Analysis: Players based in Europe (Peer Group V)
Figure 5.12 Company Competitiveness: Players based in Asia Pacific and Rest of the World (Peer Group VI)
Figure 5.13 Benchmark Analysis: Players based in Asia Pacific and Rest of the World (Peer Group VI)
Figure 5.14 Company Competitiveness: Players based in Asia Pacific and Rest of the World (Peer Group VII)
Figure 5.15 Benchmark Analysis: Players based in Asia Pacific and Rest of the World (Peer Group VII)
Figure 6.1 Bio-Techne: Annual Revenues, FY 2017- 9M 2022 (USD Million)
Figure 6.2 Charles River Laboratories: Annual Revenues, 2017- Q1 2022 (USD Billion)
Figure 6.3 Eurofins: Annual Revenues, 2017- Q1 2022 (EUR Billion)
Figure 6.4 GenScript: Annual Revenues, 2017- Q1 2022 (USD Billion)
Figure 6.5 Syngene: Annual Revenues, FY 2017- FY 2022 (INR Billion)
Figure 6.6 Twist Bioscience: Annual Revenues, FY 2017- H1 2022 (USD Million)
Figure 7.1 Patent Analysis: Distribution by Type of Patent
Figure 7.2 Patent Analysis: Cumulative Distribution by Publication Year, 2017-2022 (till May)
Figure 7.3 Patent Analysis: Cumulative Distribution by Application Year, 2017-2022 (till May)
Figure 7.4 Patent Analysis: Year-wise Distribution by Annual Number of Granted Patents and Patent Applications, 2017-2022 (till May)
Figure 7.5 Patent Analysis: Distribution by Geographical Location
Figure 7.6 Patent Analysis: Distribution by CPC Symbols
Figure 7.7 Word Cloud: Emerging Focus Areas
Figure 7.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant 2017-2022 (till May)
Figure 7.9 Leading Industry Players: Distribution by Number of Patents
Figure 7.10 Leading Non-Industry Players: Distribution by Number of Patents
Figure 7.11 Patent Analysis: Leading Individual Assignees
Figure 7.12 Patent Analysis (Leading Industry Players): Benchmarking by Patent Characteristics (CPC Symbols)
Figure 7.13 Patent Analysis: Distribution by Patent Age
Figure 7.14 Patent Valuation Analysis
Figure 8.1 Publication Analysis: Cumulative Year-wise Trend, 2018-2022 (till July)
Figure 8.2 Publication Analysis: Distribution by Type of Cloning
Figure 8.3 Word Cloud: Emerging Focus Areas
Figure 8.4 Popular Journals: Distribution by Number of Publications
Figure 8.5 Leading Authors: Distribution by Number of Publications
Figure 8.6 Leading First Authors: Distribution by Number of Publications
Figure 9.1 Global Events: Cumulative Half Yearly Trend, 2017-H1 2022
Figure 9.2 Global Events: Distribution by Event Platform
Figure 9.3 Global Events: Distribution by Type of Event
Figure 9.4 Global Events: Regional Distribution of Events
Figure 9.5 Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Area
Figure 9.6 Global Events: Historical Trend of Event Agendas, 2017-H1 2022
Figure 9.7 Most Active Participants: Distribution by Number of Events
Figure 9.8 Global Events: Distribution by Seniority Level of Event Speakers
Figure 9.9 Global Events: Distribution by Affiliated Department of Event Speakers
Figure 9.10 Global Events: Geographical Mapping of Upcoming Events
Figure 10.1 Global DNA and Gene Cloning Services Market, 2022-2035 (USD Million)
Figure 10.2 DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Services Offered
Figure 10.3 DNA and Gene Cloning Services Market for Gene Synthesis, 2022-2035 (USD Million)
Figure 10.4 DNA and Gene Cloning Services Market for Custom Cloning, 2022-2035 (USD Million)
Figure 10.5 DNA and Gene Cloning Services Market for Sub-cloning, 2022-2035 (USD Million)
Figure 10.6 DNA and Gene Cloning Services Market for Other Services, 2022-2035 (USD Million)
Figure 10.7 DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Type of Genes Cloned
Figure 10.8 DNA and Gene Cloning Services Market for Standard Gene, 2022-2035 (USD Million)
Figure 10.9 DNA and Gene Cloning Services Market for Complex Gene, 2022-2035 (USD Million)
Figure 10.10 DNA and Gene Cloning Services Market for Other Genes, 2022-2035 (USD Million)
Figure 10.11 DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Company Size
Figure 10.12 DNA and Gene Cloning Services Market for Small Companies, 2022-2035 (USD Million)
Figure 10.13 DNA and Gene Cloning Services Market for Mid-sized Companies, 2022-2035 (USD Million)
Figure 10.14 DNA and Gene Cloning Services Market for Large Companies, 2022-2035 (USD Million)
Figure 10.15 DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by End User Industry
Figure 10.16 DNA and Gene Cloning Services Market for Academic and R&D, 2022-2035 (USD Million)
Figure 10.17 DNA and Gene Cloning Services Market for Pharmaceutical and Biotechnology Companies, 2022-2035 (USD Million)
Figure 10.18 DNA and Gene Cloning Services Market for Other End Users, 2022-2035 (USD Million)
Figure 10.19 DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Key Geographical Regions
Figure 10.20 DNA and Gene Cloning Services Market in North America, 2022-2035 (USD Million)
Figure 10.21 DNA and Gene Cloning Services Market in Europe, 2022-2035 (USD Million)
Figure 10.22 DNA and Gene Cloning Services Market in Asia-Pacific, 2022-2035 (USD Million)
Figure 10.23 DNA and Gene Cloning Services Market in Latin America, 2022-2035 (USD Million)
Figure 10.24 DNA and Gene Cloning Services Market in MENA, 2022-2035 (USD Million)
Figure 11.1 DNA Cloning Kits: Distribution by Kit Components
Figure 11.2 DNA Cloning Kits: Distribution by Number of Reactions
Figure 11.3 DNA Cloning Kits: Distribution by Type of Cloning Method Used
Figure 11.4 DNA Cloning Kits: Distribution by Type of Fragment(s) Cloned
Figure 11.5 DNA Cloning Kits: Distribution by Cloning Time
Figure 11.7 DNA Cloning Kits: Distribution by Kit Shelf Life
Figure 11.8 DNA Cloning Reagents: Distribution by Unit Size
Figure 11.9 DNA Cloning Reagents: Distribution by Reagent Concentration (units/μl)
Figure 11.10 DNA Cloning Reagents: Distribution by Reagent Components
Figure 11.11 DNA Cloning Reagents: Distribution by Exonuclease Activity
Figure 11.12 DNA Cloning Reagents: Distribution by Product Overhangs
Figure 11.13 DNA Cloning Reagents: Distribution by Heat Inactivation Temperature
Figure 11.14 DNA Cloning Reagents: Distribution by Storage Temperature (?C)
Figure 11.15 DNA Cloning Kit Developers in North America
Figure 11.16 DNA Cloning Reagent Developers in North America
Figure 11.17 DNA Cloning Service Providers in North America
Figure 11.18 DNA Cloning Kit Developers in Europe
Figure 11.19 DNA Cloning Reagent Developers in Europe
Figure 11.20 DNA Cloning Service Providers in Europe
Figure 11.21 DNA Cloning Kit Developers in Asia-Pacific and Rest of the World
Figure 11.22 DNA Cloning Reagent Developers in Asia-Pacific and Rest of the World
Figure 11.23 DNA Cloning Service Providers in Asia-Pacific and Rest of the World
Figure 12.1 Concluding Remarks: Overall Market Landscape of DNA and Gene Cloning Services
Figure 12.2 Concluding Remarks: Patent Analysis
Figure 12.3 Concluding Remarks: Publication Analysis
Figure 12.4 Concluding Remarks: Global Event Analysis
Figure 12.5 Concluding Remarks: Market Forecast

List Of Tables

Table 4.1 DNA and Gene Cloning Service Providers: List of Players
Table 4.2 DNA and Gene Cloning Services: Information on Type of Service(s) Offered, Cloning Method(s) Used and Type of Gene(s) Cloned
Table 4.3 DNA and Gene Cloning Services: Information on Type of Expression System(s) Used, Cloning Vector(s) Used and End User
Table 5.1 Benchmark Analysis: Information on Peer Groups
Table 6.1 DNA, Gene and Molecular Cloning Service Providers: List of Companies Profiled
Table 6.2 Aragen Life Sciences: Company Snapshot
Table 6.3 Aragen Life Sciences: Service Portfolio
Table 6.4 Aragen Life Sciences: Recent Developments and Future Outlook
Table 6.5 Bio-Techne: Company Snapshot
Table 6.6 Bio-Techne: Service Portfolio
Table 6.7 Bio-Techne: Recent Developments and Future Outlook
Table 6.8 Charles River Laboratories: Company Snapshot
Table 6.9 Charles River Laboratories: Service Portfolio
Table 6.10 Charles River Laboratories: Recent Developments and Future Outlook
Table 6.11 Curia: Company Snapshot
Table 6.12 Curia: Service Portfolio
Table 6.13 Curia: Recent Developments and Future Outlook
Table 6.14 Eurofins: Company Snapshot
Table 6.15 Eurofins: Service Portfolio
Table 6.16 GenScript: Company Snapshot
Table 6.17 GenScript: Service Portfolio
Table 6.18 GenScript: Recent Developments and Future Outlook
Table 6.19 Integrated DNA Technologies: Company Snapshot
Table 6.20 Integrated DNA Technologies: Service Portfolio
Table 6.21 Integrated DNA Technologies: Recent Developments and Future Outlook
Table 6.22 MedGenome: Company Snapshot
Table 6.23 MedGenome: Service Portfolio
Table 6.24 MedGenome: Recent Developments and Future Outlook
Table 6.25 Sino Biological: Company Snapshot
Table 6.26 Sino Biological: Service Portfolio
Table 6.27 Sino Biological: Recent Developments and Future Outlook
Table 6.28 Syngene: Company Snapshot
Table 6.29 Syngene: Service Portfolio
Table 6.30 Syngene: Recent Developments and Future Outlook
Table 6.31 Twist Bioscience: Company Snapshot
Table 6.32 Twist Bioscience: Service Portfolio
Table 6.33 Twist Bioscience: Recent Developments and Future Outlook
Table 7.1 Patent Analysis: Prominent CPC Symbols
Table 7.2 Patent Analysis: Most Popular CPC Symbols
Table 7.3 Patent Analysis: List of Top CPC Symbols
Table 7.4 Patent Analysis: Summary of Benchmarking Analysis
Table 7.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 7.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 7.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 9.1 List of Global Events Related to DNA, Gene and Molecular Cloning
Table 13.1 Cheeky Scientist: Company Snapshot
Table 13.2 RD Biotech: Company Snapshot
Table 14.1 DNA and Gene Cloning Service Providers: Distribution by Year of Establishment
Table 14.2 DNA and Gene Cloning Service Providers: Distribution by Company Size
Table 14.3 DNA and Gene Cloning Service Providers: Distribution by Region of Headquarters
Table 14.4 DNA and Gene Cloning Service Providers: Distribution by Location of Headquarters
Table 14.5 DNA and Gene Cloning Service Providers: Distribution by Company Size and Region of Headquarters
Table 14.6 DNA and Gene Cloning Services: Distribution by Type of Service(s) Offered
Table 14.7 DNA and Gene Cloning Services: Distribution by Type of Cloning Method(s) Used
Table 14.8 DNA and Gene Cloning Services: Distribution by Type of Gene(s) Cloned
Table 14.9 DNA and Gene Cloning Services: Distribution by Type of Expression System(s) Used
Table 14.10 DNA and Gene Cloning Services: Distribution by Type of Cloning Vector(s) Used
Table 14.11 DNA and Gene Cloning Services: Distribution by End User Industry
Table 14.12 Bio-Techne: Annual Revenues, FY 2017- 9M 2022 (USD Million)
Table 14.13 Charles River Laboratories: Annual Revenues, 2017- Q1 2022 (USD Billion)
Table 14.14 Eurofins: Annual Revenues, 2017- Q1 2022 (EUR Billion)
Table 14.15 GenScript: Annual Revenues, 2017- Q1 2022 (USD Billion)
Table 14.16 Syngene: Annual Revenues, FY 2017- FY 2022 (INR Billion)
Table 14.17 Twist Bioscience: Annual Revenues, FY 2017- H1 2022 (USD Million)
Table 14.18 Patent Analysis: Distribution by Type of Patent
Table 14.19 Patent Analysis: Cumulative Distribution by Publication Year, 2017-2022 (till May)
Table 14.20 Patent Analysis: Cumulative Distribution by Application Year, 2017-2022 (till May)
Table 14.21 Patent Analysis: Year-wise Distribution by Annual Number of Granted Patents and Patent Applications, 2017-2022 (till May)
Table 14.22 Patent Analysis: Distribution by Geographical Location
Table 14.23 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant, 2017-2022 (till May)
Table 14.24 Leading Industry Players: Distribution by Number of Patents
Table 14.25 Leading Non-Industry Players: Distribution by Number of Patents
Table 14.26 Patent Analysis: Leading Individual Assignees
Table 14.27 Patent Analysis (Leading Industry Players): Benchmarking by Patent Characteristics (CPC Symbols)
Table 14.28 Patent Analysis: Distribution by Patent Age
Table 14.29 Patent Valuation Analysis
Table 14.30 Publication Analysis: Cumulative Year-wise Trend, 2018-2022 (till July)
Table 14.31 Publication Analysis: Distribution by Type of Cloning
Table 14.32 Popular Journals: Distribution by Number of Publications
Table 14.33 Leading Authors: Distribution by Number of Publications
Table 14.34 Leading First Authors: Distribution by Number of Publications
Table 14.35 Global Events: Cumulative Half Yearly Trend, 2017-H1 2022
Table 14.36 Global Events: Distribution by Event Platform
Table 14.37 Global Events: Distribution by Type of Event
Table 14.38 Global Events: Regional Distribution of Events
Table 14.39 Most Active Participants: Distribution by Number of Events
Table 14.40 Global Events: Distribution by Seniority Level of Event Speakers
Table 14.41 Global Events: Distribution by Affiliated Department of Event Speakers
Table 14.42 Global DNA and Gene Cloning Services Market, 2022-2035 (USD Million)
Table 14.43 DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Services Offered
Table 14.44 DNA and Gene Cloning Services Market for Gene Synthesis, 2022-2035 (USD Million)
Table 14.45 DNA and Gene Cloning Services Market for Custom Cloning, 2022-2035 (USD Million)
Table 14.46 DNA and Gene Cloning Services Market for Sub-cloning, 2022-2035 (USD Million)
Table 14.47 DNA and Gene Cloning Services Market for Other Services, 2022-2035 (USD Million)
Table 14.48 DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Type of Genes Cloned
Table 14.49 DNA and Gene Cloning Services Market for Standard Gene, 2022-2035 (USD Million)
Table 14.50 DNA and Gene Cloning Services Market for Complex Gene, 2022-2035 (USD Million)
Table 14.51 DNA and Gene Cloning Services Market for Other Genes, 2022-2035 (USD Million)
Table 14.52 DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Company Size
Table 14.53 DNA and Gene Cloning Services Market for Small Companies, 2022-2035 (USD Million)
Table 14.54 DNA and Gene Cloning Services Market for Mid-sized Companies, 2022-2035 (USD Million)
Table 14.55 DNA and Gene Cloning Services Market for Large Companies, 2022-2035 (USD Million)
Table 14.56 DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by End User Industry
Table 14.57 DNA and Gene Cloning Services Market for Academic and R&D, 2022-2035 (USD Million)
Table 14.58 DNA and Gene Cloning Services Market for Pharmaceutical and Biotechnology Companies, 2022-2035 (USD Million)
Table 14.59 DNA and Gene Cloning Services Market for Other End Users, 2022-2035 (USD Million)
Table 14.60 DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Key Geographical Regions
Table 14.61 DNA and Gene Cloning Services Market in North America, 2022-2035 (USD Million)
Table 14.62 DNA and Gene Cloning Services Market in Europe, 2022-2035 (USD Million)
Table 14.63 DNA and Gene Cloning Services Market in Asia-Pacific, 2022-2035 (USD Million)
Table 14.64 DNA and Gene Cloning Services Market in Latin America, 2022-2035 (USD Million)
Table 14.65 DNA and Gene Cloning Services Market in MENA, 2022-2035 (USD Million)
Table 14.66 DNA Cloning Kits: Distribution by Kit Components
Table 14.67 DNA Cloning Kits: Distribution by Number of Reactions
Table 14.68 DNA Cloning Kits: Distribution by Type of Cloning Method Used
Table 14.69 DNA Cloning Kits: Distribution by Type of Fragment(s) Cloned
Table 14.70 DNA Cloning Kits: Distribution by Cloning Time
Table 14.71 DNA Cloning Kits: Distribution by Kit Shelf Life
Table 14.72 DNA Cloning Reagents: Distribution by Unit Size
Table 14.73 DNA Cloning Reagents: Distribution by Reagent Concentration (units/μl)
Table 14.74 DNA Cloning Reagents: Distribution by Reagent Components
Table 14.75 DNA Cloning Reagents: Distribution by Exonuclease Activity
Table 14.76 DNA Cloning Reagents: Distribution by Product Overhangs
Table 14.77 DNA Cloning Reagents: Distribution by Heat Inactivation Temperature
Table 14.78 DNA Cloning Reagents: Distribution by Storage Temperature (?C)

List Of Companies

The following companies and organizations have been mentioned in the report:

  1. Addgene
  2. America Diagnostics
  3. Amid Biosciences
  4. AMSBIO
  5. Antibody Research
  6. Apexigen
  7. Applied Biological Materials 
  8. Aragen Life Sciences
  9. Asuragen
  10. ATUM
  11. Australian Institute for Bioengineering and Nanotechnology
  12. Bio Basic
  13. Biocrede
  14. Bio-Fab Research
  15. Biomyx Technology
  16. Bioneer
  17. Bionics
  18. Bio-Serv
  19. Bioss Antibodies
  20. Bio-Synthesis
  21. Bio-Techne
  22. Brigham and Women’s Hospital (BWH)
  23. Cambridge Bioscience
  24. Canvax Biotech
  25. CD BioSciences
  26. Cellomics Technology
  27. Charles River Laboratories
  28. Cheeky Scientist
  29. Chromous Biotech
  30. Cognate BioServices (acquired by Charles River Laboratories)
  31. Creative Biogene
  32. Creative Biolabs
  33. Credora Life Sciences
  34. Curia (formerly known as AMRI)
  35. Dana-Farber Cancer Institute
  36. DNA Cloning Service
  37. Duke University
  38. Epoch Life Science
  39. Blue Heron Biotech (acquired by Eurofins Genomics)
  40. Eurofins Scientific
  41. Exonbio
  42. GCC Biotech
  43. Gemini Biosciences
  44. Gene Universal
  45. GeneCopoeia
  46. GeneCust
  47. Genei Laboratories
  48. geneOmbio Technologies
  49. General Biosystems
  50. GENEWIZ (acquired by Azenta Life Sciences)
  51. Genmab
  52. Genosphere Biotechnologies
  53. GenScript
  54. GW Vitek
  55. Huazhong University of Science and Technology 
  56. IBA Lifesciences
  57. Indian Institute of Technology (IIT) Delhi 
  58. Innoprot
  59. Integrated DNA Technologies
  60. International Centre for Genetic Engineering and Biotechnology (ICGEB)
  61. INTOX (acquired by Aragen)
  62. Janssen Biotech
  63. Kyowa Kirin
  64. Labtoo
  65. LakePharma (acquired by Curia)
  66. Life Technologies (acquired by Thermo Fischer Scientific)
  67. LipExoGen Biotech
  68. Lofstrand Labs
  69. Luminous BioSciences
  70. Lundbeck
  71. Macrogen
  72. MCLAB
  73. MedGenome
  74. Molecular Diagnostic Services
  75. National Institute for Health and Medical Research (INSERM)
  76. NKMax
  77. Light Chain Bioscience (Formerly Novimmune)
  78. NZYTech
  79. OriGene Technologies
  80. Pfizer
  81. Pharma Explorer
  82. ProSpec
  83. Protein Ark
  84. PurMabiologics
  85. RD-Biotech
  86. Rx Biosciences
  87. Sentebiolab
  88. Shanghai PharmaExplorer
  89. Sino Biological
  90. Stony Brook University (SBU)
  91. Synbio Technologies
  92. Syngene
  93. System Biosciences
  94. Texas A&M University
  95. Trenzyme
  96. Twist Bioscience 
  97. University College London
  98. University of Arizona
  99. University of Helsinki
  100. University of Minnesota
  101. University of the Philippines Manila
  102. University of Texas
  103. Vigene Biosciences (acquired by Charles River Laboratories)
  104. Virginia Tech Intellectual Properties
  105. Virovek
  106. WZ Biosciences
  107. Zhejiang University

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 8) n a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com